blogs created to prevent or detect a crime

This blog is brougt to you consistent with subsection 3 of the Protection from Harassment Act - i.e. blogs created to prevent or detect a crime

Wednesday, 30 May 2012

FIDDAMAN & CCHR fail as UK treats more 5 year olds as mentally ill - Scientology campaign failed children

Children as young as FIVE are being treated for depression and anxiety... and their number is increasing by 10% each year

NHS Solent reveals that 324 young people suffering from depression were referred to it in one year

Another 378 patients, aged 16 and under, were referred for a range of mental health therapies

One child aged two was treated with 'play therapy'

By Graham Smith

PUBLISHED: 16:34, 30 May 2012
UPDATED: 16:34, 30 May 2012

Comments (25) Share

Children as young as give are being treated for depression and anxiety, according to shock NHS figures.

NHS Solent, which covers Southampton and Portsmouth, revealed it had 324 young people suffering from depression referred to it between September 2010 and August 2011.

Another 378 patients, aged 16 and under, were referred for a range of mental health therapies.

Modern scourge: Children as young as give are being treated for depression and anxiety, according to shock NHS figures

These included cognitive behaviour therapy, anxiety management and art and play therapy, with the youngest of those aged just two.

Barbara Inkson, child clinical psychology at Solent NHS Trust, said: 'Levels of emotional disorders, including depression as well as anxiety disorders and obsessive-compulsive disorders, are rising.'

She said they were seeing an annual increase of about 10 per cent in referrals.

More...Children could soon be given annual flu vaccinations at school to prevent spread of illness across all age groups

Britain's obesity crisis: NHS spending £16m a year on 200 who are too fat to leave home

Meanwhile, the NHS Children and Adolescent Mental Health Service in Sussex estimated it was working with about 330 under-11s and 830 12 to 18-year-olds with anxiety and/or depression.

Experts said children are coming under increasing stress because of unemployment, financial problems and substance abuse among their parents.

'Levels of emotional disorders, including depression as well as anxiety disorders and obsessive-compulsive disorders, are rising'Sarah Brennan, chief executive of Young Minds, said: 'Intervening early when a child or young person starts struggling to cope is proven to reduce the likelihood of that young person developing much more severe and entrenched mental health problems.

'It is vital that we invest in children and young people’s mental health in order to prevent a generation of children suffering entrenched mental health problems as adults.'

In February, MPs announced an extra £22million will be set aside to tackle child mental health treatment.

Nationally, one in ten children aged between five and 16 years old has a clinically diagnosable mental health problem.

Half of adults with long-term mental health problems will have experienced their first symptoms before the age of 14.

Read more:

Sunday, 27 May 2012 - Alexa ranking table - Google Analytics

Outbound links information for

If a site has a lot of outcoming links (these are links from the site to other sites) it is not good for the site authority, and also it can be a signal that the site is exchanging link ads. These practices are a good reason for search engines to block the sites for manipulating the results.

We found 85 outbound links to, but we show only 30 of them (0 with nofollow relation).

Our opinion is that has too many outer links. Our advice to webmasters is to decrease number of this urls. Website Link Anchor [img] 1 Boring Old Man [img] [img] ABC News Australia Alison Bass Blockbuster New Releases [img] HERE HERE Andrew Witty GSK CEO (GlaxoSmithKline) : Pharmaceutical [img] The study Widgets for Blogger announced Beyond Meds Is Something Not Quite Right With Stan - A Mental Health Blog soulful sepulcher [img] CASPER Suicides Due to Alcohol and/or Drug Overdose [img] website: The Daily Mail

Inbound links information for

More links to the web page, mean better reputation of the web page in search engines, and also if the links are from quality sites, it makes the web more reliable and more reliable and trusted.

We found 19 inbound links to Website Traffic Rank Link Anchor Date Checked 796582 Seroxat Sufferers (Paxil) 28 Jan 2012 899602 Seroxat (Paxil) Sufferers Stand Up! 18 Jul 2011 924258 Seroxat Sufferers (Paxil) 18 Jul 2011 930643 AstraZeneca's PR Machine Caught With Their Pants Down! 18 Jul 2011 978969 Bob Fiddaman 18 Jul 2011 996269 the Seroxat Sufferers Stand Up and Be Counted 01 Oct 2011 1M+ SEROXAT SUFFERERS - STAND UP AND BE COUNTED 10 Mar 2012 1M+ Seroxat Sufferers 21 Oct 2011 1M+ Fiddaman's Seroxat Sufferers 19 Jul 2011 1M+ Another blog 17 Jan 2012 1M+ fiddaman 09 Aug 2011 1M+ SEROXAT SUFFERERS - STAND UP AND BE COUNTED Justice for Seroxat/Paxil/Paroxetine users. 28 Jan 2012 1M+ Drugs Campaigner 08 Sep 2011 1M+ SEROXAT SUFFERERS - STAND UP AND BE COUNTED 28 Jan 2012 1M+ Lola's 03 Dec 2011 1M+ Seroxat Sufferers - Stand Up And Be Counted 06 Aug 2011 1M+ SEROXAT SUFFERERS - STAND UP AND BE COUNTED 21 Jan 2012 1M+ Seroxat Sufferers (Paxil) 27 Aug 2011 1M+ Seroxat (Paxil) Sufferers Stand Up and Be Counted 08 Sep 2011 uses Google Analytics with id: UA-1657564-1

HTML Validation


Result: errors, warnings



Checked: 2012-05-27It is important for your site to have valid HTML, because valid HTML will be a future pointer for the search engines, also web pages with valid HTML or XHTML will appear better in the SERPs. Our admonition is to pay attention to this and to work on validating it, because it is important. Also your site will look the same in the differing browsers. It's annoying when you see disarranged pages, isn't it?

Monday, 21 May 2012

Delivering antidepressants to brain through nose - link on FIDDAMAN blog

Delivering antidepressants to brain through nose

Researchers have developed a new way to deliver antidepressants to the brain1. They have used chitosan nanoparticles to ferry the antidepressant venlafaxine (VLF) through the nose.

Saturday, 19 May 2012

The prisoner who sued after getting sunburnt on a rooftop jail protest - fiddaman blog

The prisoner who sued after getting sunburnt on a rooftop jail protest

£10,000 a week paid out in compensation as the shocking extent of prison claim culture is revealed

ShareThisBy Deborah McAleese

Saturday, 19 May 2012

Protesting in the sun: prisoners on the roof of Maghaberry Prison in 2003

Almost £10,000 a week in compensation has been handed out to prison officers and inmates for injuries sustained in Northern Ireland’s jails.

The majority of the cash was paid following accidents, such as a fall, or for smoke inhalation during cell fires, according to Prison Service information.

And the Belfast Telegraph can reveal that one inmate lodged a compensation claim for sunburn after he climbed on to a roof in Maghaberry Prison on a hot day to stage a protest.

The protest occurred more than two years ago and the prisoner subsequently submitted the claim for compensation for his injuries.

It is not clear, however, from the information if the claim was successful as the Prison Service said that to release details of specific claims would breach human rights under the Data Protection Act.

The information, obtained under the Freedom of Information Act, shows that over the past three years more than £1.1m was spent settling 147 claims by prison staff.

Almost 80 wardens claimed for injuries sustained in an accident, such as slipping, or for smoke inhalation from cell fires. The highest single payment for an accident was £71,022.

Another 62 staff members received money for being hurt during a violent assault. One officer injured during an attack received £136,860.

The Northern Ireland Prison Service (NIPS) also paid out £332,533 to 84 prisoners over the past three years.

Fifty of the inmates received cash for hurting themselves in a fall or through smoke inhalation. The highest single payout was £25,000. Another 11 inmates received compensation following an assault, with one receiving over £18,000.

The Prison Service said that every claim made “is assessed on its own merits, with due regard for money and expenses to the public purse”.

A spokesman added that when claims are made they are dealt with robustly by the NIPS claims unit.

“Where a claim is considered to be justified, the claims unit applies a ‘Green Book’ or ‘precedent’ approach, based on that used by courts in making judgments about the quantum necessary to settle a particular type of claim,” he said.

The spokesman also said the Prison Service recently established a working group “aimed at improving the claims handling process in order to minimise costs to the public purse and to identify risks that can be managed to reduce the likelihood of future claims”.

David McNarry MLA said the amount of money paid out on compensation was “excessive” and that he believed there were problems within the system when so much was spent compensating staff and prisoners for injuries.

“It is almost a joke when you hear that people whose job it is to look after the welfare of prisoners end up getting knocked about and injured themselves, physically and mentally. And then we hear about prisoners who seem to have made some money out of being in jail,” he said.

He added: “I’m not saying that the claims are not legitimate but there must be something wrong with the structures in the service when this is allowed to happen.

“The public will be asking what is going wrong. We need every penny we can save and we cannot be throwing it away like confetti.”

But chairman of the Prison Officers’ Association (POA) Finlay Spratt said these “legitimate claims by staff show the challenging environment” they work in.

“We are entitled to a safe working environment and if officers are injured while on duty then they deserve the same rights to compensation as workers in other sectors. We work in a very volatile situation and officers get injured,” said Mr Spratt.

Justice committee chairman Paul Givan said the compensation payments “reflect the nature of the job”. “This money would not be paid out unless the Prison Service was satisfied that compensation should be awarded,” the DUP MLA added.

Read more:

Tuesday, 15 May 2012

The Seroxat litigation Bailey and others v GlaxoSmithKline (UK) Ltd. 2002 - 2012

The Seroxat litigation Bailey and others v GlaxoSmithKline (UK) Ltd. 2002 - 2012

The Background
The Product: Seroxat (chemical name paroxetine) is an antidepressant of the Selective Serotonin Re-uptake Inhibitor (SSRI) class and was the fifth in the class to be licensed. The first two were withdrawn from the market for unrelated serious adverse effects. The fourth SSRI to be licensed was Eli Lilly's Prozac. Seroxat was initially licensed in the UK as a treatment for depression in 1990. It was marketed in the UK in 1991 by SmithKlineBeecham Ltd. Today, Seroxat is marketed worldwide by GlaxoSmithKline (UK) Ltd. (GSK) under different names including Paxil in the USA. It is prescribed as a treatment for six different conditions in the UK including, Depression, Social Phobia, Obsessive Compulsive Disorder, Generalised Anxiety Disorder, Posttraumatic Stress Disorder and Panic Attacks.
BBC Panorama: In 2002, BBC Panorama reported a high number of adverse effects following antidepressant treatment with Seroxat. The adverse effects associated with the antidepressant comprise: i) withdrawal problems in response to reducing or ceasing to take Seroxat; ii) violence/aggression in response to increasing, reducing or ceasing to take Seroxat; and iii) suicidal thoughts or actions in response to increasing, reducing or ceasing to take Seroxat. During the programme, the Company denied that there were any 'addictive' properties associated with Seroxat. Nevertheless, following this programme, approx. 60,000 communications were received by the BBC describing adverse effects suffered by patients prescribed Seroxat. Several further Panorama programmes have investigated different aspects of the antidepressant's performance.
The Litigation:
Following the initial Panorama programme, Hugh James solicitors became the lead solicitors representing approximately 600 individuals who claimed that they had suffered harm when seeking to withdraw from Seroxat. A funding certificate was granted by the Legal Services Commission in 2006 and a Group Action identified as Bailey and Others v GlaxoSmithKline (UK) Ltd. was filed in the High Court in December 2007.
Case management to trial was undertaken by Senior Master Whitaker, who determined that the generic issues of the Claim should be heard at trial through lead cases selected by each party. In October 2010 and in advance of trial, Hugh James solicitors, advised the Claimants that prospects of success had diminished. Upon solicitor's advice, approximately two-thirds of the Claimants discontinued their legal action against GSK.
A core group of Claimants comprising approximately a third of the original Group Action, challenged Hugh James solicitors' decision and the solicitors' request to withdraw the public funding certificate. These Claimants considered that prospects of success remained good and stated their case through Claimant, Ms. Sarah Venn at Appeal on 14th December 2010. In response, the LSC's Special Committee Review Panel agreed to retain the funding certificate pending an independent Counsel's Opinion. In the interim period, the Panel increased the Claimants' prospects of success above that advised by Hugh James solicitors.
Dr. Sarah-Jane Richards, was the solicitor assigned to this litigation from its inception until February 2010 when she left Hugh James solicitors. Throughout that period and subsequently, she has never been in any doubt about the strength of the Claimants' case. In the event that a reasonable offer is not offered to the Claimants by the Defendants, it is her view that the litigation should continue to trial with good prospects of success. She confirmed this view to the LSC at Appeal in 2010.
In August 2011, Claimant Ms Sarah Venn instructed Dr. Richards to assist the LSC with collating and understanding the evidence supporting the litigation. Subsequently, Jacqueline Perry QC assisted by Niazi Fetto, 2 Temple Garden Chambers, were instructed in the case and have worked tirelessly alongside the three generic experts, Professor David Healy and Sarah-Jane Richards to provide the Commission with statements of support from each of the experts and an Opinion on Merits. The experts, Professor David Healy, Counsel and Dr. sarah- Jane Richards have given their time generously and without cost.
The Commission's decision on merits is anticipated in April, 2012.
For further information please contact Dr. Sarah-Jane Richards at or
telephone +44 (0)2920 786577

FIDDAMAN latest bait & switch .....get the victim story ready please

My tongue-in-cheek email asked them if their mission statement, "Helping New Zealanders to do more, feel better and live longer for over 100 years", could actually be proven and also I flippantly asked if they had any medicines that could increase my life expectancy over 100 years. I was basically having a pop at the grammar of the designer of their web page.

On asking for a copy of this study they told me:

You have contacted GlaxoSmithKline Australia/New Zealand. As product information and availability varies from country to country, we are only able to respond to enquiries originating in Australia or New Zealand.

So, just to get this straight, GlaxoSmithKline NZ cannot answer any emails that do not originate from either Australia or New Zealand yet my first email to them...the pedantic one, receives their full attention? Both emails were sent from the UK.

One has to ask if GlaxoSmithKline are picking and choosing what to answer here and, it would appear that, the only way I can get evidence of their withdrawal study would be to fly to Australia or New Zealand just to send them an email!

Well, if the mountain won't come to Mohammed....

Sunday, 13 May 2012

Seroxat may cause suicidal thinking at EARLY stage of treatment - NHS admit see FIDDAMAN blog

Seroxat (Seroxat 20mg tablets)

Information specific to: Seroxat 20mg tablets when used in Anxiety.

Seroxat (Sair-rox-at) is a medicine which is used in a number of conditions - an example is treatment of anxiety. Seroxat contains paroxetine hydrochloride. It is supplied by GlaxoSmithKline UK.

The information in this Medicine Guide for seroxat varies according to the condition being treated and the particular preparation used.

Your medicine

Seroxat is used to treat a variety of mental health problems. It is thought that Seroxat increases the activity and levels of certain chemicals in the brain. This can improve symptoms such as depression and anxiety.

Some people who take Seroxat may find that it intensifies depression and suicidal feelings in the early stages of treatment. These people have an increased risk of self-harm or suicide in the early stages of taking Seroxat. As Seroxat starts to work these risks decrease.

If you are taking Seroxat, or you care for someone who is taking Seroxat, you need to look out for changes in behaviour that could be linked to self-harm or suicide.

If you notice any of these changes or are worried about how Seroxat is affecting you or someone you care for, you should contact your prescriber, a mental health professional or NHS Direct as soon as possible.

It is important that you discuss with your prescriber how long it will take before you can expect to feel any benefits from taking Seroxat.

Do not share your medicine with other people. It may not be suitable for them and may harm them.

The pharmacy label on your medicine tells you how much medicine you should take. It also tells you how often you should take your medicine. This is the dose that you and your prescriber have agreed you should take. You should not change the dose of your medicine unless you are told to do so by your prescriber.

If you feel that the medicine is making you unwell or you do not think it is working, then talk to your prescriber.

Whether this medicine is suitable for you

Seroxat is not suitable for everyone and some people should never use it. Other people should only use it with special care. It is important that the person prescribing this medicine knows your full medical history.

Your prescriber may only prescribe this medicine with special care or may not prescribe it at all if you:

•are allergic or sensitive to or have had a reaction to any of the ingredients in the medicine

•are elderly

•are having electroconvulsive therapy

•are prone to bleeding or have had bleeding problems

•are self-harming or have self-harmed in the past

•are taking monoamine oxidase inhibitors or have taken them within the last two weeks

•have a movement disorder

•have diabetes

•have epilepsy

•have had glaucoma

•have heart problems

•have kidney problems

•have liver problems

•have narrow angle glaucoma

•have or have had mania

•have or have had suicidal thoughts or if you have attempted suicide

•have risk factors for low levels of sodium in your blood such as livercirrhosis or are taking medicines that reduce sodium levels in the blood

Furthermore the prescriber may only prescribe this medicine with special care or may not prescribe it at all for someone under 18 years of age.

As part of the process of assessing suitability to take this medicine a prescriber may also arrange tests:

•to check that this medicine is not having any undesired effects

Over time it is possible that Seroxat can become unsuitable for some people, or they may become unsuitable for it. If at any time it appears that Seroxat has become unsuitable, it is important that the prescriber is contacted immediately.


Alcohol can interact with certain medicines.

It is best to avoid drinking alcohol while you are taking this medicine.


Medicines can interact with certain foods. In some cases, this may be harmful and your prescriber may advise you to avoid certain foods.

In the case of Seroxat:

•there are no specific foods that you must exclude from your diet when taking Seroxat

Driving and operating machinery

When taking any medicine you should be aware that it might interfere with your ability to drive or operate machinery safely.

In the case of Seroxat:

•this medicine could affect your ability to drive or operate machinery

You should see how this medicine affects you before you judge whether you are safe to drive or operate machinery. If you are in any doubt about whether you should drive or operate machinery, talk to your prescriber.

Family planning and pregnancy

Most medicines, in some way, can affect the development of a baby in the womb. The effect on the baby differs between medicines and also depends on the stage of pregnancy that you have reached when you take the medicine.

In the case of Seroxat:

•you should only take this medicine during pregnancy if your doctor thinks that you need it

•if you are taking Seroxat and are planning to have a baby you must contact your prescriber

•if you become pregnant, or think you have become pregnant while taking Seroxat, you must contact your prescriber

•if you take this medicine during the late stages of pregnancy your baby may have some problems after birth

•this medicine may decrease fertility in men

You need to discuss your specific circumstances with your doctor to weigh up the overall risks and benefits of taking this medicine. You and your doctor can make a decision about whether you are going to take this medicine during pregnancy.

If the decision is that you should not have Seroxat, then you should discuss whether there is an alternative medicine that you could take during pregnancy.


Certain medicines can pass into breast milk and may reach your baby through breast-feeding.

In the case of Seroxat:

•you should only take this medicine while breast-feeding if your doctor thinks you need it

Before you have your baby you should discuss breast-feeding with your doctor or midwife. They will help you decide what is best for you and your baby based on the benefits and risks associated with this medicine. You should only breast-feed your baby while taking this medicine on the advice of your doctor or midwife.

Taking other medicines

If you are taking more than one medicine they may interact with each other. At times your prescriber may decide to use medicines that interact, in other cases this may not be appropriate.

The decision to use medicines that interact depends on your specific circumstances. Your prescriber may decide to use medicines that interact, if it is believed that the benefits of taking the medicines together outweigh the risks. In such cases, it may be necessary to alter your dose or monitor you more closely.

Tell your prescriber the names of all the medicines that you are taking so that they can consider all possible interactions. This includes all the medicines which have been prescribed by your GP, hospital doctor, dentist, nurse, health visitor, midwife or pharmacist. You must also tell your prescriber about medicines which you have bought over the counter without prescriptions.

The following medicines may interact with Seroxat:






























The following types of medicine may interact with Seroxat:



•atypical antipsychotics

•COX-2 inhibitors

•cytochrome P450 enzyme inducers

•cytochrome P450 enzyme inhibitors

•medicines that affect platelet function or increase risk of bleeding

•monoamine oxidase inhibitors

•non-steroidal anti-inflammatories

•oral anticoagulants




•serotonin precursors

•tricyclic antidepressants


If you are taking Seroxat and one of the above medicines or types of medicines, make sure your prescriber knows about it.

Complementary preparations and vitamins

Medicines can interact with complementary preparations and vitamins.

Make sure you tell your prescriber the names of all the complementary preparations and vitamins that you are taking or are planning to take.

Your prescriber can then decide whether it is appropriate for you to take combinations that are known to interact.

In the case of Seroxat:

•this medicineinteracts with St. John's Wort

If you have been prescribed Seroxat you should only take something on the above list on the specific advice of your prescriber or pharmacist.

Friday, 11 May 2012

Dr David Healy defends Electroconvulsive Therapy ....where is his evidence FIDDAMAN ?

Shocking the Homeland

May 10, 2012 1 Comment

The thriller Homeland reached its denouement in the UK at the weekend – in an Electroconvulsive Therapy (ECT) scene. Claire Danes, a Homeland security agent supposedly taking Clozapine to contain her paranoia has to distinguish reality from psychosis to save the United States (see Homeland Security). Quite obviously to anyone who knows anything about Clozapine, she was not taking it. She is having ECT, which you are expected to think will wipe her memory, when she solves the plot. Quite obviously to anyone who knows anything about ECT, this is not a reliable way to wipe her memory – giving a benzodiazepine at the key moments would have been much more reliable.

A true story?

Homeland adds to a growing list of psychiatric treatments featured as characters in plots. While inaccurate it does not portray ECT as horrifically as Clint Eastwood’s The Changeling, which starts with a clip saying it is a true story – not just based on a true story. The Changeling portrays the horrors of psychiatry as they have been since One Flew over the Cuckoo’s Nest – through involuntary ECT – even though the heroine’s incarceration happened 10 years before ECT was invented.

The only explanation for getting the history so wrong in a “true” story is that ECT inflicted in this way clearly epitomizes fears about psychiatry. But forced treatment with ECT is vanishingly rare. In practice insiders, staff and patients, are more likely to fear forcible and indefinite medication with long-acting antipsychotic injections – a treatment that is more clearly brain damaging, memory disturbing and likely to turn a person into a zombie than ECT.

Pharmacological Abuse

In terms of the greatest amount of damage done to the greatest number of people, the real abuses, the real dramas, lie in primary care treatment with prescription only drugs like the antidepressants, statins, asthma inhalers and other drugs. Where ECT given punitively, as has happened in the past, might be compared to rape, something closer to sexual abuse or sexual harassment happens with prescription drugs (see Pharmacological Abuse).

The psychiatric detention or treatment papers aren’t in evidence when we are prescribed a prescription drug. We are free to walk out the door after a consultation, and we think as a consequence that there is nothing to worry about.

But prescription links us inescapably to a prescriber. For most of us, going to the doctor is like going to the bank manager or the head teacher – we feel a few inches tall, absurdly grateful for the smallest signs of favor, and often completely forget what we had meant to say. If things begin to go wrong after treatment starts, the doctor may quickly seem like our only way out. We become ever more dependent on him, and grateful.

Stockholm syndrome

We head into a medical version of Stockholm syndrome – the puzzling state where hostages are often close to being in love with those who have taken them hostage. If the difficulties we develop are caused by the treatment and the doctor doesn’t recognise that what he is doing is wrong for us, we become hostages to fate.

It can be extraordinarily difficult to distinguish between the anxieties, insomnias, and morbid thoughts that treatments can cause even in healthy volunteers and the anxieties, insomnias and morbid thoughts stemming from the problem we took to the doctor in the first instance. It is effortless for the doctor to blame any worsening on our original problem, rather than his treatment. With much less going for them, surgeons blamed the victim faced with the evidence of memory problems after cardiac surgery, and psychiatrists routinely blame patients hooked on antidepressants or tranquilizers or who get diabetes from antipsychotics.

From stigma to reprisal

We can become isolated astonishingly quickly. If we approach someone for help in the case of an antidepressant, we have to risk the stigma of being seen to have a mental problem and then also risk being stigmatised as a loser. We risk incomprehension – even if we approach mental health professionals, none of whom are likely to side with us rather than the doctor. We risk having our next prescription increased to treat our illogical thinking. No one will call this a reprisal. If for some reason, we are listened to and treatment stops and we get worse, no-one is likely to counsel patience to help see us through what might well be a withdrawal syndrome.

Our questions will be put in the weighing scales .. and found wanting.

Our questions will be put in the weighing scales against the scientific answers and found wanting. There is no-one on our side who is likely to point out that the so-called scientific evidence has been carefully constructed by companies, who suppress trials that don’t suit their interests, and who selectively publish data from trials so that even a trial that has shown a drug fails to work and can trigger suicide can be transformed into a trial that shows unparalleled evidence of efficacy. No one to point out that pretty well all the trials published in even the best journals are likely to be ghostwritten. No-one to point out that lawyers and others looking after the interests of pharmaceutical companies regularly take advantage of medical innumeracy to hide even more dead bodies by constructing trials so the results will not be statistically significant.

As in other areas of abuse, if we wait for the abusers to recognise the problem we are likely to wait for ever. As in so many other areas from Enron to sexual abuse, it is likely to be women who will blow the whistle.

Dying for a Cure

Rebekah Beddoe’s 2007 book Dying for a Cure does this. Following a post-partum depression, Beddoe outlines a drama of seduction, increasing personal confusion, family bewilderment and finally survival against the odds.

Dying for a Cure calls out for a movie to be made of it – but we are likely to be waiting a long time for Clint Eastwood or a future episode of Homeland to take on this challenge. What stops them? In contrast to The Changeling, the problems found in Dying for a Cure are ones in which we are all complicit.

If directors are not prepared to take on the challenge, as a matter of honor they should desist from making movies like The Changeling, which by picking out the wrong villain play a part in perpetuating the kinds of abuse that makes medicine induced death possibly the leading cause of death in the Western world today.

Monday, 7 May 2012

Ritalin use for ADHD children soars fourfold - Scientology FIDDAMAN & CCHR FAIL the evidence is clear

Ritalin use for ADHD children soars fourfold

Pupils as young as three are at risk from untested drug cocktails, warn experts as prescriptions soar

Share 214

Comments (59)

Jamie Doward and Emma Craig

The Observer, Sunday 6 May 2012 Article history

More youngsters are being prescribed Ritalin for ADHD despite clinical guidelines to the contrary, say child psychologists Photograph: Murdo Macleod for the Observer

Prescriptions of Ritalin for attention deficit hyperactivity disorder have quadrupled in a decade, prompting fears it is being pushed on children at the expense of alternative treatments and without appreciation of long-term effects.

Figures released by the NHS business services authority to the Liberal Democrat MP Tessa Munt reveal the number of prescriptions of methylphenidate hydrochloride, the generic name for Ritalin, rose in England from 158,000 in 1999 to 661,463 in 2010.

Ritalin is a psychostimulant drug most commonly approved for treatment of ADHD in children. It is also used to treat conditions such as narcolepsy and in certain cases may also be prescribed for lethargy, depression and obesity.

The Association of Educational Psychologists said its members were reporting an increase in children with behavioural difficulties being prescribed the drug in conjunction with antidepressants, despite the fact there was "little to no evidence about the effect which these cocktails of drugs are having on the development of children's brains".

The association claims clinical studies show the "beneficial effects of psychostimulant medication are not sustained over the long term, necessitating stronger and stronger dosages to be prescribed over time" and that it is "becoming a common practice for children to be prescribed stronger dosages than recommended in the morning as a 'top-up' or 'kickstart' dose so that medication lasts the full school day".

Munt, who until recently sat on the education select committee, said there were natural alternatives that could help combat ADHD. She highlighted a report commissioned by the RSPB that suggested activities in a natural environment appear to improve children's symptoms by 30% compared with urban outdoor activities, and threefold compared to playing indoors. But Munt said many young people were prevented from enjoying the outdoors because of reasons such as lack of school playing fields and the distractions posed by video games, smartphones and social networking.

"It is extremely alarming that in the decade up to 2010, prescriptions for Ritalin quadrupled," she said. "Statistics show that 90% of prescriptions for this powerful drug in 2004 were used to combat behavioural problems in school-age children. I am shocked that there has been such a huge explosion in use."

ADHD is believed to affect between 5% and 10% of schoolchildren in the UK. Symptoms include overactive and impulsive behaviour and difficulty paying attention. The increase in Ritalin prescriptions appears to mirror the US where there was an 83% increase in sales of the drug between 2006 and 2010.

How many children are being prescribed the drug is difficult to quantify from official data. Munt said: "Unless the Department of Health collects vital statistical data about prescribing habits, no one will know what is happening.

"We hear teachers tell of their students' lack of ability to concentrate, from police about increasingly disruptive and antisocial behaviour, and from parents unable to control the actions of young family members. We need to show young people how to deal with the normal stresses and strains of growing up. Resorting to powerful drugs only stores up trouble for the future."

The Association of Educational Psychologists said it believed guidelines were not being followed. The guidelines recommend that ADHD medication should not be prescribed to pre-school children for the long term.nor in isolation from other therapeutic interventions, without consultation But the association said it was aware of a substantial increase in the number of children aged under six, and in some cases as young as three, being prescribed ADHD drugs. It said an informal survey of educational psychology practitioners across the West Midlands had revealed there were more than 100 children under six on the medication in the area. "This is reaffirmed across the country by our members," the association said.

FIDDAMAN CCHR Scientology FAIL as UK Ritalin prescriptions leapt four-fold in a decade

Chemical cosh drugs 'given to children aged three' as prescriptions to treat hyperactivity soarNumber of Ritalin prescriptions leapt from 158,000 in 1999 to 661,463 in 2010

By Laura Clark

PUBLISHED: 02:25, 7 May 2012
UPDATED: 02:25, 7 May 2012

Comments (41) Share

Out of control? There is evidence that children under the age of six are taking the medication

Prescriptions for ‘chemical cosh’ drugs to treat hyperactivity have soared four-fold in a decade amid evidence that children as young as three are taking the medication.

The number of prescriptions for Ritalin leapt from 158,000 in 1999 to 661,463 in 2010, NHS figures have revealed.

Psychologists said they were seeing a sharp rise in the number of children below the age of six, and some as young as three, being prescribed the drug.

They also warned dosages were getting stronger, with children increasingly given a powerful ‘kickstart’ dose in the mornings.

Ritalin – whose generic name is methylphenidate hydrochloride – can cause nausea, fatigue and mood swings and has also been linked to suicides.

Most prescriptions would have been given to those diagnosed with attention deficit hyperactive disorder, with symptoms including an inability to concentrate and restless or impulsive behaviour.

The Association of Educational Psychologists surveyed members in the West Midlands and found more than 100 children under six on medication in the area.

‘This is reaffirmed across the country,’ it said.

Figures show almost 1.7million children aged up to 16 in England – 21 per cent – were recorded with special educational needs in 2011, up from 19 per cent in 2006.

Psychologists also warned that children with behavioural problem were increasingly prescribed Ritalin in conjunction with anti-depressants.

Chemical cosh: Ritalin - whose generic name is methylphenidate hydrochloride - can cause nausea, fatigue and mood swings and has also been linked to suicides

This was despite ‘little to no evidence about the effect which these cocktails of drugs are having on the development of children’s brains’.

Read more:

Sunday, 6 May 2012

Sinn Féin & Leonie Fennell, what do they have in common FIDDAMAN?

Telling photo says it all in the body language - source

"ourselves alone"

Why low testosterone may increase your risk of diabetes

Why low testosterone may increase your risk of diabetes

By Daily Mail Reporter

PUBLISHED: 01:01, 4 May 2012
UPDATED: 01:01, 4 May 2012

Comments (14) Share

Men with low levels of testosterone could be at greater risk of developing diabetes

Men with low levels of testosterone could be at greater risk of developing diabetes, a study has suggested.

Researchers from the University of Edinburgh found low testosterone levels are linked to a resistance to insulin, the hormone that controls blood sugar levels.

Testosterone is present throughout the body and low levels are associated with increased obesity, a known risk factor for developing type 2 diabetes.

But scientists said the study provides evidence of increased risk 'even when body mass is not affected'.

Dr Kerry McInnes, from the university’s endocrinology unit, said: 'We know that men with low testosterone levels are more likely to become obese and as a result, develop diabetes.

'This study shows that low testosterone is a risk factor for diabetes no matter how much a person weighs. As men age their testosterone levels lower.

'This, along with increasing obesity, will increase the incidence of diabetes.'

The research team said the study is the first to directly show how low testosterone levels in fat tissue can be 'instrumental' in the onset of the condition.

Read more:

Friday, 4 May 2012

Britain's Got Talent 2012: Jive Aces accused of Scientology brainwashing - fiddaman blog

Britain's Got Talent 2012: Jive Aces accused of Scientology brainwashing!

Read more:

A former member of Britain’s Got Talent 2012 singers the Jive Aces have claimed they attempted to “brainwash” him into Scientology.

In an interview with The Sun today, guitarist Johnny Gunner says that the other members forced him out of the band after he refused to join their religion.

“I thought I was in danger. I was in the band to play music not be part of a secret religion,” he told the newspaper. “It got to the stage where they said join us or leave. They were a strange bunch.”

The band has made no secret about their beliefs, with singer Ian Clarkson saying: “Scientology has helped me and the band creatively. If anyone asks, I suggest people read L Ron Hubbard. There’s no brainwashing.”

A spokesperson for the band also hit out Johnny’s claims, saying: “Johnny Gunner left in 1989. The band did not become Scientologists until 1991.”

The group will find out on Saturday if they’ve made the BGT live shows.

Read more:

Thursday, 3 May 2012

wow ** Exclusive - big payout for serial litigant Bob Fiddaman

MG workers to get £3 each in trust fund compensation

Trustees have written to former directors, the Phoenix Four, to ask for donations to the trust fund Continue reading the main story

Former MG Rover workers are set to get a payout of just £3 each from a trust fund set up after the company closed down seven years ago.

Former owners Phoenix Venture Holdings had a claim against administrators Price Waterhouse Coopers thrown out by the High Court on Tuesday.

They claimed PWC should not have paid £12m to the HBOS bank because it was pledged to workers.

But HBOS said it was the bank's money to rightfully claim.

In a statement, the Lloyds Banking Group, which owns HBOS, said: "As a major lender to MG Rover we have made losses from its collapse.

"We therefore have a duty to our shareholders, including the taxpayer, to try to minimise these losses.

"It is not in anyone's gift - if indeed that is the intention - to promise to donate money to others that is not legally theirs [Phoenix Venture Holdings]."

'Workers are struggling'

There is currently £22,000 left in the trust fund that will have to be shared between 6,500 former workers.

Trustees of the fund have said all legal options to get the money back have now been exhausted.

They have now written to former directors, known as the Phoenix Four, to see if they will make donations to the trust.

Trustee Carl Chinn said: "I would ask them to do not only the honourable thing, but also the humanitarian thing.

"They should recognise the hurt, the heartache that so many people have gone through and put their hands in their pockets.

"They are all multi-millionaires now, and many former workers are struggling," he added.

Wednesday, 2 May 2012

Humiliated Toran Henry depressed for over a year - mother Maria Bradshaw previously stated FIDDAMAN

Ms Bradshaw said her son had spent the past year struggling with depression and was last year referred to Waitemata's adolescent mental health unit, Marinoto.

She said the school rejected him and suggested he go elsewhere to complete credits that were needed for a university course.

Ms Bradshaw said that while the videotaped bullying incident would have left him "humiliated", she does not believe it caused Toran's death.


Answers demanded over teen's death (+ photos)

5:00AM Monday March 31, 2008

By Elizabeth Binning, Martha McKenzie-Minifie and Craig Borley

Friends have established a memorial shrine in the garage where Toran Henry died. Photo / Dean Purcell

Friends have established a memorial shrine in the garage where Toran Henry died. Photo / Dean Purcell

* View Photos

Your Views

What can be done about violence at schools?

* Send us Your Views

* Read Your Views

Three separate investigations are under way following the death of a Takapuna Grammar student who died a day after being beaten up at the school.

Board of trustees chairwoman Jan Hill said an investigator with a legal background would be appointed this week to head the inquiry into the school's processes following the death of 17-year-old Toran Henry.

Ms Hill said Toran's death was a "serious matter" that would get the board's full attention.

"We will be inviting anyone who believes they can contribute to this investigation to do so. This is the only way we can truly address the allegations which have been raised."

The Waitemata District Health Board and the police are also investigating the incident, which happened at Toran's home 12 days ago.

His death - which has been referred to the coroner - came just hours after a series of phone conversations with mental health case workers that reportedly left the teen distressed.

Toran was involved in a fight at the school the day before he died, and students are understood to have filmed the incident.



North Shore police area commander Les Paterson said he had assigned a small team of very experienced investigators to the case and would be "keeping an eye on developments".

But Toran's mother, Maria Bradshaw, and his friends yesterday criticised authorities.

Ms Bradshaw said her son had spent the past year struggling with depression and was last year referred to Waitemata's adolescent mental health unit, Marinoto.

She said the school rejected him and suggested he go elsewhere to complete credits that were needed for a university course.

Ms Bradshaw said that while the videotaped bullying incident would have left him "humiliated", she does not believe it caused Toran's death.

On the day he died, he had several conversations with his case workers about the incident, and became upset after one told him he would be reported to the police if he retaliated against the boy who had beaten him.

Two hours later, Ms Bradshaw found Toran dead in the garage.

Toran's friends - who have established a garage shrine in his honour - claim the school bullied and harassed him and was too quick to give up on problem students.

"He couldn't do anything," said Jason Taylor, 18. "He had tried so hard. If they just gave him extra attention he would have been out of that school in a month. There's no doubt in my mind if that had happened he would still be here."

The friends said they had become more like a family than mates in the past two weeks. They saw that camaraderie as their best defence against depression and its repercussions.

But one Takapuna Grammar student who contacted the Herald last night said she was unaware of a bullying problem at the school and was amazed by the claims surrounding Toran's death.

"[Toran] and his friends weren't angels. I feel the deepest sadness and sympathy for his friends and family, but please do not make this about my school. I'm proud to attend TGS and do not want its reputation tainted."

The student also played down the significance of a "fight club" that supposedly existed at the school.

"I have seen it once, the day Toran came. It was controlled and had rules - it was in no way brutal.

"Boxing gloves were used, no one was ever hurt, safety was a priority and at the end of the fight all grudges were forgotten and the participants would shake hands and hug."

Toran's friends also said the alleged "fight club" did not exist to any great extent and had "nothing to do" with his death.

Education Minister Chris Carter said he was concerned bullying might have contributed to the tragic events and had "strongly encouraged" a thorough investigation by Takapuna Grammar.

"Every school must ensure a safe environment for its students."

The Director of Mental Health, Dr David Chaplow, said the Ministry of Health had called for an internal inquiry and would determine the next steps after the investigation was completed.

Waitemata District Health Board is also investigating and extended "sincere condolences and sympathy" to Toran's family.

GlaxoSmithKline - popular visitor to FIDDAMAN blog